Epstein-Barr Virus DNA Loads in Adult Human Immunodeficiency Virus Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy

Clinical Infectious Diseases

Volumn 37, Issue 9, 2003, Pages 1244-1249

  Ling, Paul D ^a   Vilchez, Regis A ^a   Keitel, Wendy A ^a   Poston, David G ^a   Peng, Rong Sheng ^a   White, Zoe S ^a   Visnegarwala, Fehmida ^a   Lewis, Dorothy E ^a   Butel, Janet S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS DNA;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME QUANTITATIVE POLYMERASE CHAIN REACTION; SALIVA LEVEL; VIRUS LOAD;

NASA DISCIPLINE REGULATORY PHYSIOLOGY; NASA PROGRAM BIOMEDICAL RESEARCH AND COUNTERMEASURES; NON-NASA CENTER;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; MALE; POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 0242659111     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/378808     Document Type: Article

References (49)

1. Thorley-Lawson DA. Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 2001; 1:75-82.
2. Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM, Griffin DE, et al., eds. Fields virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001:2575-627.
3. Borza CM, Hutt-Fletcher LM. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 2002; 8:594-9.
4. Telenti A, Uehlinger DE, Marchesi F, Germann D, Malinverni R, Matter L. Epstein-Barr virus infection in HIV-positive patients. Eur J Clin Microbiol Infect Dis 1993; 12:601-9.
5. Brandt CD, Sison AV, Rakusan TA, et al. Epstein-Barr virus DNA in the blood of infants, young children, and adults by age and HIV status. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17:69-72.
6. Hoang MP, Rogers BB, Dawson DB, Scheuermann RH. Quantitation of 8 human herpesviruses in peripheral blood of human immunodeficiency virus-infected patients and healthy blood donors by polymerase chain reaction. Am J Clin Pathol 1999; 111:655-9.
7. Birx DL, Redfield RR, Tosato G. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med 1986; 314:874-9.
8. Sumaya CV, Boswell RN, Ench Y, et al. Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS-related complex. J Infect Dis 1986; 154:864-70.
9. Alsip GR, Ench Y, Sumaya CV, Boswell RN. Increased Epstein-Barr virus DNA in oropharyngeal secretions from patients with AIDS, AIDS-related complex, or asymptomatic human immunodeficiency virus infections. J Infect Dis 1988; 157:1072-6.
10. Diaz-Mitoma F, Ruiz A, Flowerdew G, et al. High levels of Epstein-Barr virus in the oropharynx: a predictor of disease progression in human immunodeficiency virus infection. J Med Virol 1990; 31:69-75.
11. Ferbas J, Rahman MA, Kingsley LA, et al. Frequent oropharyngeal shedding of Epstein-Barr virus in homosexual men during early HIV infection. AIDS 1992; 6:1273-8.
12. Jenson H, McIntosh K, Pitt J, et al. Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1. J Infect Dis 1999; 179:1395-404.
13. Mueller N. Overview of the epidemiology of malignancy in immune deficiency. J Acquir Immune Defic Syndr 1999; 21:55-10.
14. Butel JS. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 2000; 21:405-26.
15. Crawford DH. Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 2001; 356:461-73.
16. Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. AIDS-Cancer Match Registry Study Group. JAMA 2001; 285:1736-45.
17. Vilchez RA, Madden CR, Kozinetz CA, et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002; 359:817-23.
18. Vilchez RA, Lednicky JA, Halvorson SJ, White ZS, Kozinetz CA, Butel JS. Detection of polyomavirus simian virus 40 tumor antigen DNA in AIDS-related systemic non-Hodgkin lymphoma. J Acquir Immune Defic Syndr 2002; 29:109-16.
19. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853-60.
20. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, hepatitis C and sexually transmitted infections in Australia: annual surveillance report 1999. Sydney, Australia: National Centre in HIV Epidemiology and Clinical Research, 1999.
21. Knowles DM. Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 1996; 10:1081-109.
22. Sandler AS, Kaplan L. AIDS lymphoma. Curr Opin Oncol 1996; 8:377-85.
23. Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, Autran B. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998; 351:1682-6.
24. Pezzotti P, Pappagallo M, Phillips AN, et al. Response to highly active antiretroviral therapy according to duration of HIV infection. J Acquir Immune Defic Syndr 2001; 26:473-9.
25. Matthews GV, Bower M, Mandalia S, Powles T, Nelson MR, Gazzard BG. Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy. Blood 2000; 96:2730-4.
26. Rabkin CS. AIDS and cancer in the era of highly active antiretroviral therapy (HAART). Eur J Cancer 2001; 37:1316-9.
27. Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998; 352:1725-30.
28. Jacobson LP, Yamashita TE, Detels R, et al. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1999; 21(Suppl 1):S34-41.
29. Jones JL, Hanson DL, Dworkin MS, Ward JW, Jaffe HW. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult/Adolescent Spectrum of HIV Disease Project Group. J Acquir Immune Defic Syndr 1999; 21(Suppl 1):S11-7.
30. Ledergerber B, Egger M, Erard V, et al. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA 1999; 282:2220-6.
31. Ledergerber B, Telenti A, Egger M. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study. BMJ 1999; 319:23-4.
32. Mocroft A, Katlama C, Johnson AM, et al. AIDS across Europe, 1994-98: the EuroSIDA study. Lancet 2000; 356:291-6.
33. Vilchez RA, Kozinetz CA, Butel JS. The changing incidence of four AIDS-related malignancies in a large urban center. AIDS Patient Care and STDs 2001; 15:405-6.
34. Vilchez RA, Kozinetz CA, Jorgensen JL, Kroll MH, Butel JS. AIDS-related systemic non-Hodgkin's lymphoma at a large community program. AIDS Res Hum Retroviruses 2002; 18:237-42.
35. Vilchez RA, Finch CJ, Jorgensen JL, Butel JS. The clinical epidemiology of Hodgkin's lymphoma in HIV-infected patients in the HAART era. Medicine (Baltimore) 2003; 82:77-81.
36. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000; 92:1823-30.
37. Righetti E, Ballon G, Ometto L, et al. Dynamics of Epstein-Barr virus in HFV-1-infected subjects on highly active antiretroviral therapy. AIDS 2002; 16:63-73.
38. O'Sullivan CE, Peng RS, Cole KS, et al. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART. J Med Virol 2002; 67:320-6.
39. Stevens SJ, Blank BS, Smits PH, Meenhorst PL, Middeldorp JM. High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology. AIDS 2002; 16:993-1001.
40. Sambrook I, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
41. Savoldo B, Huls MH, Liu Z, et al. Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection. Blood 2002; 100:4059-66.
42. Hoffman RA, Kung PC, Hansen WP, Goldstein G. Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. Proc Natl Acad Sci USA 1980; 77:4914-7.
43. Lewis DE, Ng Tang DS, Wang X, Kozinetz C. Costimulatory pathways mediate monocyte-dependent lymphocyte apoptosis in HIV. Clin Immunol 1999; 90:302-12.
44. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41:961-2.
45. Lednicky JA, Vilchez RA, Keitel WA, et al. Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy. AIDS 2003; 17:801-7.
46. Gaidano G, Dalla-Favera R. Molecular pathogenesis of AIDS-related lymphoma. Adv Cancer Res 1995; 67:113-53.
47. Fais F, Fronza G, Roncella S, et al. Analysis of stepwise genetic changes in an AIDS-related Burkitt's lymphoma. Int J Cancer 2000; 88:744-50.
48. Van Baarle D, Wolthers KC, Hovenkamp E, et al. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma. J Infect Dis 2002; 186:405-9.
49. + T cells is associated with progression to viral disease in HIV-infection. AIDS 2002; 16:2001-11.